Show Nav →

Overview Data source: UniProt

Official Gene Symbol Other Aliases
MAPK1 ERK2, PRKM1, PRKM2
Sequence Length (AA) Molecular Weight (Da)
360 41390
Protein Name
Mitogen-activated protein kinase 1
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MAAAAAAGAG PEMVRGQVFD VGPRYTNLSY IGEGAYGMVC SAYDNVNKVR
60 70 80 90 100
VAIKKISPFE HQTYCQRTLR EIKILLRFRH ENIIGINDII RAPTIEQMKD
110 120 130 140 150
VYIVQDLMET DLYKLLKTQH LSNDHICYFL YQILRGLKYI HSANVLHRDL
160 170 180 190 200
KPSNLLLNTT CDLKICDFGL ARVADPDHDH TGFLTEYVAT RWYRAPEIML
210 220 230 240 250
NSKGYTKSID IWSVGCILAE MLSNRPIFPG KHYLDQLNHI LGILGSPSQE
260 270 280 290 300
DLNCIINLKA RNYLLSLPHK NKVPWNRLFP NADSKALDLL DKMLTFNPHK
310 320 330 340 350
RIEVEQALAH PYLEQYYDPS DEPIAEAPFK FDMELDDLPK EKLKELIFEE
360
TARFQPGYRS

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-1352 Collapse assay details

Data source: Panorama

Official Gene Symbol
MAPK1
Peptide Modified Sequence
VADPDHDHTGFLT[+80.0]EY[+80.0]VATR
Modification Type
Phospho (ST), Phospho (Y)
Protein - Site of Modification
185, 187
Peptide - Site of Modification
13, 15
Peptide Start
173
Peptide End
191
CPTAC ID
CPTAC-1352
Peptide Molecular Mass
2,302.9297
Species
Homo sapiens (Human)
Assay Type
Enrichment PRM
Enrichment Method
N/A
Matrix
digested cell lysate
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Mol Cell Proteomics. 2016 May;15(5):1622-41. doi: 10.1074/mcp.M116.058354. Epub 2016 Feb 24. Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes. Abelin JG1, Patel J1, Lu X1, Feeney CM1, Fagbami L1, Creech AL1, Hu R1, Lam D1, Davison D1, Pino L1, Qiao JW1, Kuhn E1, Officer A1, Li J2, Abbatiello S1, Subramanian A1, Sidman R2, Snyder E3, Carr SA1, Jaffe JD4.

View Details (opens in a new window)

Mol Cell Proteomics. 2014 Jul;13(7):1690-704. doi: 10.1074/mcp.M113.036392. Epub 2014 Apr 9. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mertins P1, Yang F2, Liu T2, Mani DR3, Petyuk VA2, Gillette MA3, Clauser KR3, Qiao JW3, Gritsenko MA2, Moore RJ2, Levine DA4, Townsend R5, Erdmann-Gilmore P5, Snider JE5, Davies SR5, Ruggles KV6, Fenyo D6, Kitchens RT5, Li S5, Olvera N4, Dao F4, Rodriguez H7, Chan DW8, Liebler D9, White F10, Rodland KD2, Mills GB11, Smith RD2, Paulovich AG12, Ellis M5, Carr SA1


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva
Internal Standard
light stable isotope peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y16-98 (2+) 7.6 5.7 7.5 14.2 10.5 10.4 16.1 11.9 12.8 15 15 15
y5 (1+) 5.2 5 6.4 7.6 10.6 11 9.2 11.7 12.7 15 15 15
y7-98 (1+) 6.3 4.6 3 6.2 9.4 5.3 8.8 10.5 6.1 15 15 15
sum 5 3.8 3.9 5.6 9.3 7.6 7.5 10 8.5 15 15 15

Additional Resources and Comments


Assay Details for CPTAC-1353 Collapse assay details

Data source: Panorama

Official Gene Symbol
MAPK1
Peptide Modified Sequence
VADPDHDHTGFLT[+80.0]EYVATR
Modification Type
Phospho (ST)
Protein - Site of Modification
185
Peptide - Site of Modification
13
Peptide Start
173
Peptide End
191
CPTAC ID
CPTAC-1353
Peptide Molecular Mass
2,222.9634
Species
Homo sapiens (Human)
Assay Type
Enrichment PRM
Enrichment Method
N/A
Matrix
digested cell lysate
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Mol Cell Proteomics. 2016 May;15(5):1622-41. doi: 10.1074/mcp.M116.058354. Epub 2016 Feb 24. Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes. Abelin JG1, Patel J1, Lu X1, Feeney CM1, Fagbami L1, Creech AL1, Hu R1, Lam D1, Davison D1, Pino L1, Qiao JW1, Kuhn E1, Officer A1, Li J2, Abbatiello S1, Subramanian A1, Sidman R2, Snyder E3, Carr SA1, Jaffe JD4.

View Details (opens in a new window)

Mol Cell Proteomics. 2014 Jul;13(7):1690-704. doi: 10.1074/mcp.M113.036392. Epub 2014 Apr 9. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mertins P1, Yang F2, Liu T2, Mani DR3, Petyuk VA2, Gillette MA3, Clauser KR3, Qiao JW3, Gritsenko MA2, Moore RJ2, Levine DA4, Townsend R5, Erdmann-Gilmore P5, Snider JE5, Davies SR5, Ruggles KV6, Fenyo D6, Kitchens RT5, Li S5, Olvera N4, Dao F4, Rodriguez H7, Chan DW8, Liebler D9, White F10, Rodland KD2, Mills GB11, Smith RD2, Paulovich AG12, Ellis M5, Carr SA1


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva
Internal Standard
light stable isotope peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b11 (1+) 29.4 16.5 23.7 24.3 16.6 25.8 38.1 23.4 35 12 13 13
y6 (1+) 12.4 14 6.5 11.4 12.1 12.7 16.8 18.5 14.3 15 15 15
y7-98 (1+) 8.2 9.4 6.8 11.9 9.2 8.5 14.5 13.2 10.9 15 15 15
sum 7.7 8.8 6.2 9.9 9.3 9.3 12.5 12.8 11.2 15 15 15

Additional Resources and Comments


Assay Details for CPTAC-1354 Collapse assay details

Data source: Panorama

Official Gene Symbol
MAPK1
Peptide Modified Sequence
VADPDHDHTGFLTEY[+80.0]VATR
Modification Type
Phospho (Y)
Protein - Site of Modification
187
Peptide - Site of Modification
15
Peptide Start
173
Peptide End
191
CPTAC ID
CPTAC-1354
Peptide Molecular Mass
2,222.9634
Species
Homo sapiens (Human)
Assay Type
Enrichment PRM
Enrichment Method
N/A
Matrix
digested cell lysate
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Mol Cell Proteomics. 2016 May;15(5):1622-41. doi: 10.1074/mcp.M116.058354. Epub 2016 Feb 24. Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes. Abelin JG1, Patel J1, Lu X1, Feeney CM1, Fagbami L1, Creech AL1, Hu R1, Lam D1, Davison D1, Pino L1, Qiao JW1, Kuhn E1, Officer A1, Li J2, Abbatiello S1, Subramanian A1, Sidman R2, Snyder E3, Carr SA1, Jaffe JD4.

View Details (opens in a new window)

Mol Cell Proteomics. 2014 Jul;13(7):1690-704. doi: 10.1074/mcp.M113.036392. Epub 2014 Apr 9. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mertins P1, Yang F2, Liu T2, Mani DR3, Petyuk VA2, Gillette MA3, Clauser KR3, Qiao JW3, Gritsenko MA2, Moore RJ2, Levine DA4, Townsend R5, Erdmann-Gilmore P5, Snider JE5, Davies SR5, Ruggles KV6, Fenyo D6, Kitchens RT5, Li S5, Olvera N4, Dao F4, Rodriguez H7, Chan DW8, Liebler D9, White F10, Rodland KD2, Mills GB11, Smith RD2, Paulovich AG12, Ellis M5, Carr SA1


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva
Internal Standard
light stable isotope peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b11 (2+) 8.3 5.7 6 8.5 9.1 10.3 11.9 10.7 11.9 15 15 15
y5 (1+) 7.5 3.8 5.1 7.6 9.3 9.7 10.7 10 11 15 15 15
y7 (1+) 4.9 2.8 5.3 5.5 7.8 9.8 7.4 8.3 11.1 15 15 15
sum 5.5 2.7 4.8 6 8 9.7 8.1 8.4 10.8 15 15 15

Additional Resources and Comments


Assay Details for CPTAC-870 Collapse assay details

Data source: Panorama

Official Gene Symbol
MAPK1
Peptide Sequence
AAAAAAGAGPEMVR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
2
Peptide End
15
CPTAC ID
CPTAC-870
Peptide Molecular Mass
1,241.6187
Species
Homo sapiens (Human)
Assay Type
Direct PRM
Matrix
Pooled patient derived xenograft breast tumor digest
Submitting Laboratory
Washington University in St. Louis
Submitting Lab PI
Reid Townsend

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
TripleTOF 5600+ (SCIEX)
Internal Standard
Peptide
Peptide Standard Purity
Crude
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
2DPlus nano-LC (Eksigent)
Column Packing
ChromXP C18-CL, 3 µm, 120 Å
Column Dimensions
200 µm x 15 cm
Flow Rate
800 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y3 (1+) 22.5 14.6 10.1 28.3 11.3 9.4 36.2 18.5 13.8 15 15 15
y5 (1+) 13.4 9.9 11.9 14.1 11.2 16.3 19.5 14.9 20.2 15 15 15
y6 (1+) 13.9 5 5.3 16 9 6.6 21.2 10.3 8.5 15 15 15
y7 (1+) 10.2 9 11.5 17.4 10.8 12.4 20.2 14.1 16.9 15 15 15
y8 (1+) 14.4 4.5 6.9 12.1 6.3 9.3 18.8 7.7 11.6 15 15 15
y9 (1+) 8.3 4.6 8.1 9.6 9.1 8.8 12.7 10.2 12 15 15 15
y10 (1+) 10 4.7 4.9 11.4 6.5 7.4 15.2 8 8.9 15 15 15
y11 (1+) 18.1 12 10.5 21.3 13.2 11.2 28 17.8 15.4 15 15 15
b6 (2+) 8.1 7.6 8.5 13.4 10.4 9.4 15.7 12.9 12.7 15 15 15
b5 (1+) 22.7 13.7 15.1 26.3 16.1 17.6 34.7 21.1 23.2 15 15 15
b4 (1+) 14.6 11 11.2 17.2 13 11.8 22.6 17 16.3 15 15 15
sum 4 3 3.6 6.2 6 6.1 7.4 6.7 7.1 15 15 15

Additional Resources and Comments


Assay Details for CPTAC-871 Collapse assay details

Data source: Panorama

Official Gene Symbol
MAPK1
Peptide Sequence
ELIFEETAR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
345
Peptide End
353
CPTAC ID
CPTAC-871
Peptide Molecular Mass
1,106.5608
Species
Homo sapiens (Human)
Assay Type
Direct PRM
Matrix
Pooled patient derived xenograft breast tumor digest
Submitting Laboratory
Washington University in St. Louis
Submitting Lab PI
Reid Townsend

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
TripleTOF 5600+ (SCIEX)
Internal Standard
Peptide
Peptide Standard Purity
Crude
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
2DPlus nano-LC (Eksigent)
Column Packing
ChromXP C18-CL, 3 µm, 120 Å
Column Dimensions
200 µm x 15 cm
Flow Rate
800 nL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y3 (1+) 15 6.7 6.3 14 7.2 7.1 20.5 9.8 9.5 15 15 15
y4 (1+) 8.3 5.1 4.8 8.4 7.1 6.2 11.8 8.7 7.8 15 15 15
y5 (1+) 6.2 3.5 2.3 8 4.8 4.4 10.1 5.9 5 15 15 15
y6 (1+) 4.6 1.8 2.6 6.9 3.3 3.1 8.3 3.8 4 15 15 15
y7 (1+) 5 5.7 4.2 7.3 4.7 3.9 8.8 7.4 5.7 15 15 15
sum 3.8 1.5 1.7 5.9 3.5 2.8 7 3.8 3.3 15 15 15

Additional Resources and Comments